Stock Earnings

Question 1

BioCryst Pharmaceuticals Incの主要な財務諸表は何ですか？

Accepted Answer

最新の財務諸表（Form-10K）によると、BioCryst Pharmaceuticals Incの総資産は$490で、純lossは$-88です。

Question 2

BCRXの主要な財務比率は何ですか？

Accepted Answer

BioCryst Pharmaceuticals Incの流動比率は0.5、純利益率は-19.55、1株当たり売上高は$2.17です。

Question 3

BioCryst Pharmaceuticals Incの収益はセグメントまたは地域別にどのように分けられていますか？

Accepted Answer

BioCryst Pharmaceuticals Inc largest revenue segment is Oral Small-molecule and Injectable Protein Therapeutics, at a revenue of 450,712,000 in the most earnings release.For geography, United States is the primary market for BioCryst Pharmaceuticals Inc, at a revenue of 385,961,000.

Question 4

BioCryst Pharmaceuticals Incは収益を上げていますか？

Accepted Answer

no、最新の財務諸表によると、BioCryst Pharmaceuticals Incの純lossは$-88です。

Question 5

BioCryst Pharmaceuticals Incに負債はありますか？

Accepted Answer

yes、BioCryst Pharmaceuticals Incの負債は966です。

Question 6

BioCryst Pharmaceuticals Incの発行済株式数は何株ですか？

Accepted Answer

BioCryst Pharmaceuticals Incの総発行済株式数は208.54株です。

Breakdown	TTM	12/31/2024	12/31/2023	12/31/2022	12/31/2021	12/31/2020
Revenue	557	450	331	270	157	17
Revenue Growth (YoY)	46%	36%	23%	72%	824%	-65%
Cost of Revenue	16	12	4	6	7	1
Gross Profit	540	438	326	264	149	16
Selling, General & Admin	315	266	213	159	118	67
Research & Development	171	174	215	253	208	123
Operating Expenses	486	440	428	412	327	190
Other Non Operating Income (Expenses)	--	--	--	--	--	--
Pretax Income	-32	-86	-226	-244	-181	-182
Income Tax Expense	3	1	0	2	2	--
Net Income	-35	-88	-226	-247	-184	-182
Net Income Growth	-76%	-61%	-9%	34%	1%	69%
Shares Outstanding (Diluted)	219.88	206.69	192.19	185.9	179.1	167.3
Shares Change (YoY)	7%	8%	3%	4%	7%	45%
EPS (Diluted)	-0.17	-0.43	-1.17	-1.33	-1.03	-1.09
EPS Growth	-75%	-64%	-11%	28.99%	-6%	16%
Free Cash Flow	0	-53	-97	-163	-144	-135
Free Cash Flow Per Share	0	-0.25	-0.5	-0.87	-0.8	-0.8
Gross Margin	96.94%	97.33%	98.48%	97.77%	94.9%	94.11%
Operating Margin	9.69%	-0.44%	-30.81%	-54.81%	-112.73%	-1,023.52%
Profit Margin	-6.28%	-19.55%	-68.27%	-91.48%	-117.19%	-1,070.58%
Free Cash Flow Margin	0%	-11.77%	-29.3%	-60.37%	-91.71%	-794.11%
EBITDA	55	-1	-101	-147	-177	-174
EBITDA Margin	9.87%	-0.22%	-30.51%	-54.44%	-112.73%	-1,023.52%
D&A For EBITDA	1	1	1	1	0	0
EBIT	54	-2	-102	-148	-177	-174
EBIT Margin	9.69%	-0.44%	-30.81%	-54.81%	-112.73%	-1,023.52%
Effective Tax Rate	-9.37%	-1.16%	0%	-0.81%	-1.1%	--

BioCryst Pharmaceuticals Inc (BCRX) Price

BCRX Stock Price Chart

BCRX Income

Follow-Up Questions